Back to search

Article

TAK1 blockade as a therapy for retinal neovascularization

2021-01-29

Abstract excerpt

<h4>ABSTRACT</h4> Retinal neovascularization, or pathological angiogenesis in the retina, is a leading cause of blindness in developed countries. Transforming growth factor-β-activated kinase 1 (TAK1) is a mitogen-activated protein kinase kinase kinase (MAPKKK) activated by TGF-β1 and other pro-inflammatory cytokines. TAK1 is also a key mediator of inflammation, innate immune responses, apoptosis and tissue homeo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ada32dcd-3d15-5a94-977e-7451f7e7e680
DOI
10.1101/2021.01.29.428701
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TAK1 blockade as a therapy for retinal neovascularizationDOI 10.1101/2021.01.29.428701
Select a neighboring publication to make it the new centre.